Question 1

What is the catalog number for NaPi2b/SLC34A2 (Lifastuzumab) discontinued?

Accepted Answer

The catalog number for NaPi2b/SLC34A2 (Lifastuzumab) discontinued is 048221.

Question 2

What sizes are available for NaPi2b/SLC34A2 (Lifastuzumab) discontinued?

Accepted Answer

NaPi2b/SLC34A2 (Lifastuzumab) discontinued is available in the following size(s): 100 µg.

Question 3

Is NaPi2b/SLC34A2 (Lifastuzumab) discontinued in stock?

Accepted Answer

NaPi2b/SLC34A2 (Lifastuzumab) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 5

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 6

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

NaPi2b/SLC34A2 (Lifastuzumab) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

5-Chloro-2-furancarbonyl Chloride (~ 90%)

Epstein-Barr Virus (LMP-1) (CS4), 0.2mg/mL

BRCC45 (BRE) (NM_199194) Human Over-expression Lysate

Carbofuran N-Butylthiohydroxylamine

CD61 (ITGB3) Rabbit Polyclonal Antibody

Human NAP1 (NAA25) activation kit by CRISPRa